Stock
Quotient
.
Explore
Leaderboards
How we score
Search companies
⌘K
Sign in
Sign up
free
Bringing the fundamentals into focus…
← All sectors
Healthcare leaderboard
448 fully scored companies
Market
All markets
US-listed (3,593)
Canada (223)
United Kingdom (254)
Europe (1,297)
Japan (1,164)
Hong Kong (612)
China (2,873)
Taiwan (443)
South Korea (357)
Australia & NZ (359)
India (521)
Singapore (134)
Southeast Asia (601)
Middle East (186)
Brazil (183)
Latin America (135)
Other markets (35)
Size
All sizes
Large ($10B+)
Mid ($2B–10B)
Small ($300M–2B)
Micro (under $300M)
Overall score
Any score
40 and above
60 and above
80 and above
Sort by
Overall score
Valuation
Growth
Profitability
Lowest risk
Market cap
Company name
Rank
Company
Price
Overall score
Valuation
Growth
Profitability
Risk
1
ABUS
Arbutus Biopharma Corporation
ABUS · US-listed
· 658M USD
$4.29
-4.24%
97
/ 100
96
98
99
0 / 2
2
LKFT
Lakefront Biotherapeutics NV
LKFT · US-listed
Beta
· 2.0B USD
$30.00
+2.32%
97
/ 100
97
99
93
0 / 2
3
INVA
Innoviva, Inc.
INVA · US-listed
· 1.5B USD
$21.06
+1.10%
93
/ 100
94
91
93
0 / 2
4
ZVRA
Zevra Therapeutics, Inc.
ZVRA · US-listed
· 658M USD
$11.08
+3.26%
91
/ 100
94
100
99
0 / 2
5
AUPH
Aurinia Pharmaceuticals Inc.
AUPH · US-listed
· 2.1B USD
$16.01
+2.04%
84
/ 100
90
93
96
1 / 2
6
INCY
Incyte Corporation
INCY · US-listed
· 23.0B USD
$113.44
+0.63%
84
/ 100
83
82
98
0 / 2
7
HCSG
Healthcare Services Group, Inc.
HCSG · US-listed
· 1.4B USD
$20.79
-1.61%
82
/ 100
88
87
92
1 / 2
8
CRMD
CorMedix Inc.
CRMD · US-listed
· 567M USD
$7.28
+0.00%
81
/ 100
▲ 1
96
99
99
2 / 2
9
MGTX
MeiraGTx Holdings plc
MGTX · US-listed
· 1.0B USD
$10.82
+2.08%
81
/ 100
93
98
99
1 / 2
10
ADMA
ADMA Biologics, Inc.
ADMA · US-listed
· 2.3B USD
$10.14
-0.39%
80
/ 100
▼ 1
84
67
98
0 / 2
11
CUVL
Clinuvel Pharmaceuticals Limited
CUVL · US-listed
Beta
· 292M USD
$5.80
+2.29%
80
/ 100
98
35
92
0 / 2
12
INSP
Inspire Medical Systems, Inc.
INSP · US-listed
· 2.0B USD
$67.45
-1.10%
80
/ 100
▲ 1
72
84
76
0 / 2
13
ARGX
argenx SE
ARGX · US-listed
· 57.7B USD
$928.44
-0.22%
79
/ 100
42
96
93
0 / 2
14
GMED
Globus Medical, Inc.
GMED · US-listed
· 9.9B USD
$73.75
-3.51%
79
/ 100
79
85
84
0 / 2
15
HRMY
Harmony Biosciences Holdings, Inc.
HRMY · US-listed
· 2.3B USD
$39.34
-0.05%
79
/ 100
▲ 1
90
75
95
1 / 2
16
LGND
Ligand Pharmaceuticals Incorporated
LGND · US-listed
· 5.8B USD
$293.26
-1.24%
79
/ 100
52
90
86
0 / 2
17
LMAT
LeMaitre Vascular, Inc.
LMAT · US-listed
· 1.8B USD
$79.31
+0.33%
79
/ 100
60
74
90
0 / 2
18
ANIP
ANI Pharmaceuticals, Inc.
ANIP · US-listed
· 1.7B USD
$71.93
+0.57%
78
/ 100
90
89
85
1 / 2
19
EXEL
Exelixis, Inc.
EXEL · US-listed
· 14.5B USD
$58.44
+0.19%
78
/ 100
75
68
99
0 / 2
20
KRYS
Krystal Biotech, Inc.
KRYS · US-listed
· 9.6B USD
$324.57
-0.69%
78
/ 100
▲ 1
49
80
94
0 / 2
21
RIGL
Rigel Pharmaceuticals, Inc.
RIGL · US-listed
· 896M USD
$47.99
+4.08%
78
/ 100
91
88
93
1 / 2
22
NBIX
Neurocrine Biosciences, Inc.
NBIX · US-listed
· 14.6B USD
$143.47
-1.40%
77
/ 100
69
87
91
1 / 2
23
NUTX
Nutex Health Inc.
NUTX · US-listed
Beta
· 1.5B USD
$213.02
-2.46%
76
/ 100
96
89
99
2 / 2
24
UTHR
United Therapeutics Corporation
UTHR · US-listed
· 23.4B USD
$545.00
+0.62%
76
/ 100
73
53
95
0 / 2
25
ACAD
Acadia Pharmaceuticals Inc.
ACAD · US-listed
· 3.4B USD
$19.65
-0.46%
75
/ 100
▼ 1
82
80
80
1 / 2